Elsevier

Immunology Letters

Volume 106, Issue 1, 15 July 2006, Pages 1-7
Immunology Letters

Current Views
“Dirty little secrets”—Endotoxin contamination of recombinant proteins

https://doi.org/10.1016/j.imlet.2006.04.007Get rights and content

Abstract

The identification of Toll-like receptors has revolutionised our understanding of innate immunity. TLR4 transduces the LPS signal and that of a number of structurally and functionally unrelated agonists. However, recent evidence adds to longstanding concerns that endotoxin contamination of bacterially derived recombinant TLR4 agonists is responsible for effects attributed to these molecules. We highlight key factors in differentiating specific agonist effects from those of endotoxin and emphasize why conventional methods of detecting and eliminating LPS may lead to erroneous results. We propose that considerable caution is needed in the investigation of TLR4 agonists, particularly when using proteins produced in a bacterium that also houses the most ideal TLR4 agonist, LPS.

Introduction

Lipopolysaccharide (LPS), an integral component of the outer membrane of Gram negative bacteria, is a potent stimulant of the immune system [1]. LPS is the main cause of septic shock in humans, a syndrome characterised by the massive release of proinflammatory cytokines, activation of clotting and complement cascades, and activation of leukocytes. Following the discovery of Toll in Drosophila, the identification of a family of mammalian Toll-like receptors (TLRs) that recognise and signal in response to conserved molecular patterns (pathogen-associated molecular patterns) present within bacteria has transformed our understanding of innate immunity [2], [3], [4], [5], [6].

Section snippets

TLR4 and its agonists

Many TLR agonists are bacterial in origin reflecting the variety of microbial components that need to be recognised by the innate immune system (Fig. 1). Upon activation, TLRs signal as dimers, complexing via their intracellular Toll/interleukin-1 receptor (TIR) domains with a family of adaptor proteins in TLR-specific patterns. This results in the activation of downstream pathways including the NF-κB pathway, the MAP kinases, phosphatidylinositol-3′-kinase (PI-3K), and the interferon

The nature of the stimulus

Recently, a body of evidence has emerged to suggest that some of the effects previously attributed to the TLR4 agonists HSP60 and HSP70 may be the direct result of low amounts of endotoxin contained within the bacterial-derived recombinant proteins used experimentally to investigate their roles in vitro [34], [35], [36], though studies controlling carefully for endotoxin have still identified roles for these proteins in the activation of TLR4 [37]. There is also recent evidence that the heat

Detecting the contaminants

Given the potency of the many bacterial products that may contribute to signalling through one or more of the TLRs, it is vital that effects attributable to such products are differentiated from effects relating to the protein of interest. This relies on our ability not only to detect and quantify accurately the activity of the bacterial contaminants present but also to remove or neutralise them. It is important to emphasize that the methods available target LPS alone, thus failing to account

Decontaminating the contaminants

The removal of endotoxin from proteins is difficult [64]. If LPS is the only bacterial contaminant present, a number of methods have been described in the literature for its removal [65], [66], [67]. These include adsorption by activated carbon, anion-exchange chromatography, Triton X phase separation, the use of polymeric matrices and treatment with polymyxin B (PMB) or histamine-immobilised sepharose. Most have been designed with a clinical purpose in mind, producing products that do not

Future

The discovery of the TLRs is revolutionising our understanding of innate immunity and it is now clear that the TLRs represent a very specific mechanism for the recognition of bacterial molecular patterns. TLR signalling is complex but although much headway has been made, we still are far from understanding all the interactions that take place during signal transduction. TLR4 has been the centre of intense interest and a number of exogenous and endogenous agonists have been proposed. The full

References (87)

  • B. Gao et al.

    Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages

    J Biol Chem

    (2003)
  • T. Matsuguchi et al.

    Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes

    Blood

    (2000)
  • J. Watanabe et al.

    Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity

    J Biol Chem

    (2003)
  • Y. Kang et al.

    Chromatographic removal of endotoxin from hemoglobin preparations. Effects of solution conditions on endotoxin removal efficiency and protein recovery

    J Chromatogr A

    (1998)
  • C. Hirayama et al.

    Chromatographic removal of endotoxin from protein solutions by polymer particles

    J Chromatogr B Analyt Technol Biomed Life Sci

    (2002)
  • Y. Aida et al.

    Removal of endotoxin from protein solutions by phase separation using Triton X-114

    J Immunol Methods

    (1990)
  • D. Petsch et al.

    Endotoxin removal from protein solutions

    J Biotechnol

    (2000)
  • S. Liu et al.

    Removal of endotoxin from recombinant protein preparations

    Clin Biochem

    (1997)
  • M.J. Wilson et al.

    Removal of tightly bound endotoxin from biological products

    J Biotechnol

    (2001)
  • C. Damais et al.

    Induction of human interleukin-1 production by polymyxin B

    J Immunol Methods

    (1987)
  • J.M. Cavaillon et al.

    Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin

    Mol Immunol

    (1986)
  • M. Vaara et al.

    Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium

    FEBS Lett

    (1981)
  • D.C. Morrison et al.

    The use of polymyxin B and C3H/HeJ mouse spleen cells as criteria for endotoxin contamination

    J Immunol Methods

    (1979)
  • D.T. Golenbock et al.

    Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes

    J Biol Chem

    (1991)
  • W.A. Lynn et al.

    Lipopolysaccharide antagonists

    Immunol Today

    (1992)
  • E.V. Vikstrom

    The immunosuppressive activity of chemically modified lipopolysaccharide of Shigella sonnei

    Immunol Lett

    (2002)
  • B. Beutler et al.

    Innate immune sensing and its roots: the story of endotoxin

    Nat Rev Immunol

    (2003)
  • I. Sabroe et al.

    Toll-like receptors in health and disease: complex questions remain

    J Immunol

    (2003)
  • R. Medzhitov

    Toll-like receptors and innate immunity

    Nat Rev Immunol

    (2001)
  • S. Uematsu et al.

    The role of Toll-like receptors in immune disorders

    Expert Opin Biol Ther

    (2006)
  • K. Takeda et al.

    Toll-like receptors

    Annu Rev Immunol

    (2003)
  • S. Akira et al.

    Toll-like receptors: critical proteins linking innate and acquired immunity

    Nat Immunol

    (2001)
  • A. Poltorak et al.

    Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene

    Science

    (1998)
  • S.T. Qureshi et al.

    Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)

    J Exp Med

    (1999)
  • S. Akashi et al.

    Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14

    J Exp Med

    (2003)
  • T.L. Gioannini et al.

    Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations

    Proc Natl Acad Sci USA

    (2004)
  • A. Visintin et al.

    Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4

    Proc Natl Acad Sci USA

    (2001)
  • P.Y. Perera et al.

    CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression

    J Immunol

    (2001)
  • C. Termeer et al.

    Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4

    J Exp Med

    (2002)
  • G.B. Johnson et al.

    Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4

    J Immunol

    (2002)
  • S.T. Smiley et al.

    Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4

    J Immunol

    (2001)
  • L. Guillot et al.

    Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4

    J Immunol

    (2002)
  • K. Ohashi et al.

    Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex

    J Immunol

    (2000)
  • Cited by (0)

    View full text